ResearcherCentral South UniversityActive in the last 2 years

Shubing Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2819-8023; OpenAlex author ID A5036566042. Sources: OpenAlex.

Their work

Papers: 4 (first author 2, last author 2)
Trials: 0
Grants: 0
Labs led: 1
Collaborators: 7

Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 2 papers

Papers 4

Lfng-expressing centroacinar cell is a unique cell-of-origin for p53 deficient pancreatic cancer. First author DOI 10.1038/s41388-024-03226-7 ↗
Calothrixin B by docking JAK2 is a potential therapeutic inhibitor for pancreatic ductal adenocarcinoma. Last author DOI 10.1093/jpp/rgae149 ↗
The role of amino acid metabolism alterations in pancreatic cancer: From mechanism to application. Last author DOI 10.1016/j.bbcan.2023.188893 ↗
Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreati… First author DOI 10.1186/s12885-021-08550-9 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Wen-Cheng Chung · 1 shared paper, 2025 · strength 0.37
- Paper Lfng-expressing centroacinar cell is a unique cell-of-origin for p53 deficient pancreatic cancer. DOI 10.1038/s41388-024-03226-7 ↗
Keli Xu · 1 shared paper, 2025 · strength 0.37
- Paper Lfng-expressing centroacinar cell is a unique cell-of-origin for p53 deficient pancreatic cancer. DOI 10.1038/s41388-024-03226-7 ↗
Azeddine Atfi · 1 shared paper, 2025 · strength 0.37
- Paper Lfng-expressing centroacinar cell is a unique cell-of-origin for p53 deficient pancreatic cancer. DOI 10.1038/s41388-024-03226-7 ↗
Shenao Fu · 1 shared paper, 2023 · strength 0.31
- Paper The role of amino acid metabolism alterations in pancreatic cancer: From mechanism to application. DOI 10.1016/j.bbcan.2023.188893 ↗
Yang Wang · 1 shared paper, 2025 · strength 0.23
- Paper Calothrixin B by docking JAK2 is a potential therapeutic inhibitor for pancreatic ductal adenocarcinoma. DOI 10.1093/jpp/rgae149 ↗
Yuanhong Xu · 1 shared paper, 2021 · strength 0.14
- Paper Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tu… DOI 10.1186/s12885-021-08550-9 ↗
Lianzi Wang · 1 shared paper, 2021 · strength 0.14
- Paper Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tu… DOI 10.1186/s12885-021-08550-9 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.